NCT05812807 2026-03-04
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
Clinical Trials
29 trialsNCT05976763 2026-03-04
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT04425421 2026-03-02
GFALMB2019
French Africa Pediatric Oncology Group
Recruiting
NCT04425434 2026-03-02
GFARB12019
French Africa Pediatric Oncology Group
Recruiting
NCT05840484 2026-02-19
Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance
M.D. Anderson Cancer Center
Recruiting
NCT03516617 2026-02-09
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Mayo Clinic
Phase 2 Recruiting
NCT05810467 2026-02-04
AS
Institute of Cancer Research, United Kingdom
Recruiting
NCT07370675 2026-01-27
Active Surveillance for Bethesda IV Thyroid Nodules
Rigshospitalet, Denmark
Phase NA Recruiting
NCT07025226 2026-01-26
Senolytics
Mayo Clinic
Phase EARLY_PHASE1 Recruiting
NCT03180268 2026-01-14
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
NRG Oncology
Phase 3 Recruiting
NCT06378866 2025-12-26
DIVINE
Mayo Clinic
Phase 2 Recruiting
NCT03803553 2025-12-23
Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
Massachusetts General Hospital
Phase 3 Recruiting
NCT07270861 2025-12-08
Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study
Fudan University
Recruiting
NCT07262138 2025-12-03
ACTIVE
University of Pittsburgh
Recruiting
NCT06200103 2025-09-11
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Mayo Clinic
Phase 2 Recruiting
NCT02609685 2025-09-09
PMCAS
Cedars-Sinai Medical Center
Phase NA Recruiting
NCT03911128 2025-09-02
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Karolinska University Hospital
Recruiting
NCT06537154 2025-07-30
NEO-BLAST
University of British Columbia
Phase 2/3 Recruiting
NCT05375617 2025-05-31
EPICkids
Columbia University
Recruiting
NCT00949819 2025-05-13
ASCaP
Jonsson Comprehensive Cancer Center
Recruiting
NCT04625023 2025-05-01
METAMECH
IFOM ETS - The AIRC Institute of Molecular Oncology
Recruiting
NCT06539468 2025-04-02
Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients
University of Michigan Rogel Cancer Center
Phase NA Recruiting
NCT06238648 2024-09-26
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
Academic and Community Cancer Research United
Phase 2 Recruiting
NCT02760238 2024-08-27
Myeloproliferative Neoplasms (MPNs) Patient Registry
University Health Network, Toronto
Recruiting
NCT04886635 2024-02-20
SANO-2
Erasmus Medical Center
Recruiting
NCT03804320 2020-02-11
Protocol Active Surveillance Small Renal Masses (SRMs)
IRCCS San Raffaele
Phase NA Recruiting
NCT04135664 2019-10-22
Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital
Phase 3 Recruiting
NCT02971085 2019-02-12
SUPER-PC-AS
Seoul National University Hospital
Recruiting
NCT03253536 2017-08-18
LIVERCARE
Ludwig-Maximilians - University of Munich
Recruiting